NovaBridge Biosciences (NBP) Ending Cash Balance (2018 - 2026)
NovaBridge Biosciences' Ending Cash Balance came in at $190.64 million for Q2 2026, up 15.3% from $165.4 million a year earlier.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Ending Cash Balance (2018 - 2026) Analysis & Trends
For FY2025, NovaBridge Biosciences' Ending Cash Balance was $210.63 million, up 208.6% from FY2024.
- Ending Cash Balance carries a five-year compound annual growth rate of -22.4% (FY2020 to FY2025).
- Going back by year, Ending Cash Balance was $68.26 million in FY2024 (-78.0%), $310.67 million in FY2023 (-34.6%), $475.37 million in FY2022 (-14.0%) and $552.67 million in FY2021 (-26.0%).
- The five-year range for quarterly Ending Cash Balance is $68.26 million (Q4 2024) to $554.02 million (Q2 2022).
- Year-over-year, Ending Cash Balance increased in four of the last five quarters, with growth averaging 68.4%.
- The fastest year-over-year change in Ending Cash Balance over five years came in Q4 2025 (growth of 208.6%), and the weakest in Q4 2024 (a decline of 78.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | NovaBridge Biosciences | 99.23 Mn | -696.35 Mn | - | 190.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 190.64 Mn |
| Dec 31, 2025 | 210.63 Mn |
| Sep 30, 2025 | 228.06 Mn |
| Jun 30, 2025 | 165.40 Mn |
| Dec 31, 2024 | 68.26 Mn |
| Sep 30, 2024 | 79.33 Mn |
| Jun 30, 2024 | 151.96 Mn |
| Dec 31, 2023 | 310.67 Mn |
| Dec 31, 2022 | 475.37 Mn |
| Jun 30, 2022 | 554.02 Mn |
| Dec 31, 2021 | 552.98 Mn |
| Jun 30, 2021 | 673.06 Mn |
| Dec 31, 2020 | 729.63 Mn |
| Sep 30, 2020 | 435.96 Mn |
| Jun 30, 2020 | 220.36 Mn |
| Dec 31, 2019 | 170.82 Mn |
| Sep 30, 2019 | 179.88 Mn |
| Dec 31, 2018 | 244.42 Mn |
API Access
NovaBridge Biosciences Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();